COCP: Cocrystal Pharma, Inc. Cash on Hand per Share

Corporate emblem and logo of Cocrystal Pharma, Inc. (COCP)

Cash per share demonstrates current liquidity, where the parameter value reaches 0.26. Cocrystal Pharma, Inc. (COCP) utilizes protein crystallography to create structural barriers against viral replication. The issuer's revenues will be based on the market launch of therapies against COVID-19, influenza, and norovirus. Operating within the US jurisdiction minimizes geopolitical risks, ensuring legal protection for the business.

cocrystalpharma.com (COCP) Cash per Single Share: for the period 07/04/2022 - 11/20/2026

Analytical breakdowns for Cocrystal Pharma, Inc.

- market capitalization information:
- cash position and cash flow details:
General company analysis:Cocrystal Pharma Corp - COCP
Core merchandise of cocrystalpharma.com

Cash per share measures the portion of liquid assets attributable to a single security, determining the issuer's financial autonomy. For Cocrystal Pharma, Inc. (COCP), this resource is critical as it ensures the independence of academic R&D centers and the payment of options to leading virologists. By analyzing the cash per share chart, one can assess the capital burn rate. A rising trend confirms stability, while a sharp decline signals the risk of external borrowing.